Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Contrave Extended-Release | naltrexone hydrochloride and bupropion hydrochloride | tablet, extended release, oral | 51267-890NDA |
Enquiry
Common questions
- Is Nalpropion Pharmaceuticals LLC FDA approved?
- Nalpropion Pharmaceuticals LLC holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Nalpropion Pharmaceuticals LLC make?
- 1 product is listed under Nalpropion Pharmaceuticals LLC in the openFDA NDC Directory, most often as tablet, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.